XBiotech Inc.XBITNASDAQ

Revenue (LTM)

Net Income (LTM)

$-46M

-18.2% YoY

Free Cash Flow

$-40M

Revenue CAGR (5Y)

—

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	18	4↓78.2%	0	0	0
Gross Profit	13	3↓73.3%	0	0	-2
Operating Income	-25	-34↓37.5%	-38↓8.8%	-42↓13.2%	-56↓31.1%
Net Income	-17	-33↓88.9%	-25↑25.4%	-39↓56.9%	-46↓18.2%
EBITDA	-22	-32↓42.1%	-23↑29.2%	-36↓59.6%	-54↓50.0%
EPS Diluted	-0.58	-1.08↓86.2%	-0.81↑25.0%	-1.26↓55.6%	-1.49↓18.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	237	157↓33.6%	200↑27.2%	173↓13.7%	126↓27.3%
Total Current Assets	247	220↓10.9%	202↓8.2%	175↓13.5%	127↓27.3%
Total Assets	275	246↓10.6%	227↓7.9%	199↓12.1%	150↓24.6%
Total Current Liabilities	3	4↑17.8%	6↑50.0%	15↑147.6%	8↓47.5%
Total Liabilities	6	6↓1.6%	8↑36.3%	17↑116.6%	10↓42.2%
Total Equity	269	240↓10.8%	219↓9.0%	182↓16.7%	140↓23.0%
Total Debt	0	0	0	10	0
Net Debt	-237	-157↑33.6%	-200↓27.2%	-162↑18.8%	-126↑22.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	69	-15↓121.3%	-19↓26.3%	-31↓65.4%	-40↓28.9%
Capital Expenditure	-4	-1↑83.4%	-0↑38.1%	-1↓260.2%	-0↑77.8%
Free Cash Flow	66	-15↓123.4%	-19↓23.9%	-32↓69.1%	-40↓24.6%
Stock-Based Comp	4	5↑13.4%	3↓35.6%	2↓46.3%	4↑106.6%
Net Change in Cash	-0	-80↓20703.4%	43↑153.6%	-27↓164.0%	-47↓72.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance